This POAP was given to the colleagues that participated at the regular Bayer Pharmaceuticals Nordics and Baltics Innovation meeting to discuss current and future projects. Art by OpenAI Dall-E 2. https://twitter.com/bayer_danmark https://twitter.com/bayernorway https://twitter.com/BayerSuomi https://twitter.com/BayerSverigeAB

This POAP was given to the colleagues that participated at the regular Bayer Pharmaceuticals Nordics and Baltics Innovation meeting to discuss current and future projects. Art by OpenAI Dall-E 2. https://twitter.com/bayer_danmark https://twitter.com/bayernorway https://twitter.com/BayerSuomi https://twitter.com/BayerSverigeAB

This POAP was given to the colleagues that participated at the regular Bayer Pharmaceuticals Nordics and Baltics Innovation meeting to discuss current and future projects. Art by OpenAI Dall-E 2. https://twitter.com/bayer_danmark https://twitter.com/bayernorway https://twitter.com/BayerSuomi https://twitter.com/BayerSverigeAB

This POAP was given to the colleagues that participated at the regular Bayer Pharmaceuticals Nordics and Baltics Innovation meeting to discuss current and future projects. Art by OpenAI Dall-E 2. https://twitter.com/bayer_danmark https://twitter.com/bayernorway https://twitter.com/BayerSuomi https://twitter.com/BayerSverigeAB

This POAP was given to the colleagues that participated at the regular Bayer Pharmaceuticals Nordics and Baltics Innovation meeting to discuss current and future projects. Art by OpenAI Dall-E 2. https://twitter.com/bayer_danmark https://twitter.com/bayernorway https://twitter.com/BayerSuomi https://twitter.com/BayerSverigeAB